IntrinsicIntrinsic
← All summaries

Cayson Acquisition Corp

CAPN
Financials & Chart →

Business Summary

Cayson Acquisition Corp (the "Company") operates as a blank check company, incorporated in the Cayman Islands on May 27, 2024, with the sole purpose of effecting a business combination such as a merger, share exchange, asset acquisition, stock purchase, or reorganization with one or more businesses . The Company has not generated any operating revenues to date and does not expect to do so until the completion of its initial business combination . Its primary business objective is to identify and acquire a target business, with a stated focus on businesses in Asia, though it is not limited to any specific industry or geographic region . The Company explicitly states it will not consummate its initial business combination with an entity or business with China operations consolidated through a variable interest entity (VIE) structure .

The Company's core business model is that of a Special Purpose Acquisition Company (SPAC). It raised capital through an Initial Public Offering (IPO) and a private placement, with the majority of proceeds held in a Trust Account to be used for a business combination . Revenue generation is currently limited to non-operating income in the form of interest earned on these investments . The primary customer segment, in essence, is the target business it seeks to acquire, as its success is entirely dependent on the future performance of that single business post-combination .

For the fiscal year ended December 31, 2025, the Company reported a net income of $1,637,488 . This was primarily driven by interest earned on cash and investments held in the Trust Account, amounting to $2,535,846 , and bank interest income of $9,644 . These gains were partially offset by formation and operating costs of $908,002 . The Company's cash balance as of December 31, 2025, was $63,670 , a decrease from $465,254 as of December 31, 2024 . Cash and investments held in the Trust Account increased to $64,487,925 as of December 31, 2025, from $60,752,079 as of December 31, 2024 . The Company reported a working capital deficit of $1,157,343 as of December 31, 2025 . Total liabilities as of December 31, 2025, were $3,409,330 , including a deferred underwriting commission payable of $2,100,000 and promissory notes totaling $1,200,000 ($900,000 from a third party and $300,000 from a related party) . The Company's total shareholders' deficit was $(3,257,343) as of December 31, 2025 .

Comparing the fiscal year ended December 31, 2025, to the period from May 27, 2024 (inception) through December 31, 2024, net income increased from $475,489 to $1,637,488 . This improvement was largely due to a significant increase in interest earned on cash and investments held in the Trust Account, which rose from $752,079 in the prior period to $2,535,846 in 2025. Formation and operating costs also increased from $281,186 to $908,002 year-over-year. Cash used in operating activities was $(401,584) for the year ended December 31, 2025 , compared to $(369,218) for the period from inception through December 31, 2024 . Cash used in investing activities for 2025 was $(1,200,000) , representing extension payments into the Trust Account, a notable shift from $(60,000,000) in 2024 which represented the initial investment of cash into the Trust Account . Cash provided by financing activities was $1,200,000 in 2025 , primarily from promissory notes, contrasting with $60,834,472 in 2024 from the IPO and private placement .

A significant operational development during the reported period was the Company entering into an Agreement and Plan of Merger (the "Merger Agreement") on July 11, 2025, with Mango Financial Group Limited, North Water Investment Group Holdings Limited, and Mango Temp Limited . Pursuant to this agreement, the Company will become a wholly-owned subsidiary of Mango Financial Group Limited upon closing . Additionally, on March 18, 2026, shareholders approved amendments to the Company's articles of association to allow for monthly extensions of the business combination deadline up to March 23, 2027, contingent on the Sponsors, officers, directors, affiliates, or designees lending $125,000 for each month utilized . In connection with this, holders of 2,541,908 public shares exercised their redemption rights for approximately $10.83 per share, totaling approximately $27,536,646 . Mango Financial subsequently agreed to lend $750,000, with the first $125,000 deposited into the Trust Account on March 19, 2026, to extend the deadline to April 23, 2026 .

Business Outlook

The Company's primary outlook is centered on completing its initial business combination, with a current deadline of March 23, 2027, assuming monthly extensions are utilized . Management explicitly states that it intends to effectuate its initial business combination using cash from the proceeds of its IPO and private placement, proceeds from the sale of its securities in connection with the business combination, its shares, debt, or a combination thereof . If the cash portion of the purchase price exceeds the amount available from the Trust Account, net of redemptions, the Company may need to seek additional financing .

A major growth area for the Company is the pending merger with Mango Financial Group Limited, as described in the Merger Agreement entered into on July 11, 2025 . Upon closing, the Company will become a wholly-owned subsidiary of Mango Financial Group Limited, which will become the parent company of Mango Financial . While the filing does not provide specific revenue or margin contributions expected from this acquisition, it represents the Company's strategic path to becoming an operating entity. The Company's search for target businesses is focused on Asia, but it will not pursue targets with China operations consolidated through a variable interest entity (VIE) structure .

Regarding operational outlook, the Company expects to incur increased expenses as a public company for legal, financial reporting, accounting, and auditing compliance, as well as for due diligence in connection with searching for and completing a business combination . Management has identified a working capital deficit of $1,157,343 as of December 31, 2025 , and believes it may have insufficient funds to operate prior to its initial business combination . To address this, the Sponsors, officers, directors, or their affiliates may loan funds on a non-interest bearing basis, with up to $1,500,000 of such loans convertible into working capital units at $10.00 per unit .

The Company's planned capital allocation involves using substantially all funds in the Trust Account, including interest earned (less income taxes payable), to complete its business combination . Any remaining proceeds will be used as working capital for the target business, other acquisitions, and growth strategies . Funds held outside the Trust Account are intended for existing accounts payable, identifying and evaluating target businesses, due diligence, travel, reviewing corporate documents, structuring and completing a business combination, and directors and officers liability insurance premiums . The underwriters are entitled to a deferred underwriting discount of 3.5% of the IPO's gross proceeds, or $2,100,000, payable upon the closing of an initial business combination .

Management has explicitly flagged that the Company may have insufficient funds to sustain operations for a reasonable period of time prior to its initial business combination, raising substantial doubt about its ability to continue as a going concern . Furthermore, the ability to complete a business combination may be impacted by the fact that certain of the Sponsors' limited partners are non-U.S. persons, and a majority of officers and directors have significant ties to China, potentially limiting the pool of acquisition candidates outside the PRC . The Company also faces risks related to U.S. foreign investment regulations and CFIUS review, which could block or delay a business combination with a U.S. target .

Risk Factors

The Company faces several material risks, including the fundamental risk of being a blank check company with no operating history or revenues, meaning there is no basis to evaluate its ability to achieve its business objective . There is a significant risk that the Company may not complete its initial business combination within the prescribed timeframe of March 23, 2027, which would lead to liquidation, with public shareholders potentially receiving only approximately $10.00 per share, or less in certain circumstances, and Rights expiring worthless . Intense competition from other blank check companies, private equity groups, and operating businesses for acquisition opportunities could increase the cost of a business combination or prevent the Company from finding a suitable target . The ability of public shareholders to redeem their shares for cash, particularly if a large number do so, could make the Company's financial condition unattractive to potential targets or prevent it from meeting closing conditions requiring a minimum net worth or cash amount . If third parties bring claims against the Company, the proceeds in the Trust Account could be reduced, leading to a per-share redemption amount less than $10.00 . The Company's current working capital deficit of $1,157,343 as of December 31, 2025, raises substantial doubt about its ability to continue as a going concern . Furthermore, the fact that certain Sponsors' limited partners are non-U.S. persons and a majority of officers and directors have significant ties to China may limit the pool of non-PRC acquisition candidates due to U.S. foreign investment regulations and potential CFIUS review . If the Company acquires a business outside the United States, it would be subject to additional risks such as currency fluctuations, tariffs, unpredictable legal systems, and political instability . Specifically, if a business in the PRC is acquired, it would be subject to complex and evolving PRC laws and regulations regarding foreign investment, antitrust, cybersecurity, and data protection, which could delay or prevent a business combination or lead to penalties .

Management Priorities

Management's overall tone emphasizes the Company's commitment to completing an initial business combination, acknowledging the challenges inherent in its blank check company structure. They explicitly state the Company's objective to effect a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or entities . A key strategic priority is the ongoing pursuit of a business combination, as evidenced by the Merger Agreement with Mango Financial Group Limited and the subsequent shareholder approval to extend the deadline for completion . Management has secured an agreement for Mango Financial to lend an aggregate of $750,000, with the first $125,000 already deposited into the Trust Account to extend the deadline to April 23, 2026 . Another strategic priority is managing liquidity and capital resources, as the Company has a working capital deficit of $1,157,343 as of December 31, 2025, and may rely on loans from Sponsors, officers, directors, or their affiliates to fund working capital deficiencies or transaction costs . Management also highlights the importance of compliance with regulatory requirements, including those related to being a public company, and has identified internal control deficiencies related to segregation of duties and written policies, which they intend to remediate by expanding and improving review processes and considering additional staff .

View Source Annual Report on SEC.gov ↗

References

  1. [1] Item 1, Business
  2. [2] Item 7, MD&A — Results of Operations
  3. [3] Item 1, Business
  4. [4] Item 1, Business
  5. [5] Item 1, Business
  6. [6] Item 7, MD&A — Results of Operations
  7. [7] Item 1, Business — Lack of Business Diversification
  8. [8] Item 7, MD&A — Results of Operations
  9. [9] Item 7, MD&A — Results of Operations
  10. [10] Item 7, MD&A — Results of Operations
  11. [11] Item 7, MD&A — Results of Operations
  12. [12] Item 7, MD&A — Liquidity, Capital Resources and Going Concern
  13. [13] Item 7, MD&A — Liquidity, Capital Resources and Going Concern
  14. [14] Item 7, MD&A — Liquidity, Capital Resources and Going Concern
  15. [15] Item 7, MD&A — Liquidity, Capital Resources and Going Concern
  16. [16] Item 8, Balance Sheets
  17. [17] Item 8, Balance Sheets
  18. [18] Item 8, Balance Sheets
  19. [19] Item 8, Balance Sheets
  20. [20] Item 7, MD&A — Results of Operations
  21. [21] Item 7, MD&A — Results of Operations
  22. [22] Item 7, MD&A — Results of Operations
  23. [23] Item 7, MD&A — Results of Operations
  24. [24] Item 7, MD&A — Results of Operations
  25. [25] Item 7, MD&A — Results of Operations
  26. [26] Item 7, MD&A — Liquidity, Capital Resources and Going Concern
  27. [27] Item 7, MD&A — Liquidity, Capital Resources and Going Concern
  28. [28] Item 7, MD&A — Liquidity, Capital Resources and Going Concern
  29. [29] Item 7, MD&A — Liquidity, Capital Resources and Going Concern
  30. [30] Item 7, MD&A — Liquidity, Capital Resources and Going Concern
  31. [31] Item 7, MD&A — Liquidity, Capital Resources and Going Concern
  32. [32] Item 1, Business
  33. [33] Item 1, Business
  34. [34] Item 1, Business
  35. [35] Item 1, Business
  36. [36] Item 1, Business
  37. [37] Item 1A, Risk Factors — We may not be able to complete our initial business combination within the prescribed time frame
  38. [38] Item 1, Business
  39. [39] Item 1, Business
  40. [40] Item 1, Business
  41. [41] Item 1, Business
  42. [42] Item 1, Business
  43. [43] Item 7, MD&A — Results of Operations
  44. [44] Item 7, MD&A — Liquidity, Capital Resources and Going Concern
  45. [45] Item 7, MD&A — Liquidity, Capital Resources and Going Concern
  46. [46] Item 7, MD&A — Liquidity, Capital Resources and Going Concern
  47. [47] Item 7, MD&A — Liquidity, Capital Resources and Going Concern
  48. [48] Item 7, MD&A — Liquidity, Capital Resources and Going Concern
  49. [49] Item 7, MD&A — Liquidity, Capital Resources and Going Concern
  50. [50] Item 7, MD&A — Other Contractual Obligations
  51. [51] Item 7, MD&A — Liquidity, Capital Resources and Going Concern
  52. [52] Item 1A, Risk Factors — Our ability to complete a business combination may be impacted by the fact that certain of our Sponsors’ limited partners are non-U.S. persons
  53. [53] Item 1A, Risk Factors — Our ability to complete a business combination may be impacted by the fact that certain of our Sponsors’ limited partners are non-U.S. persons
  54. [54] Item 1A, Risk Factors — We are a Cayman Islands exempted company with no operating history and no revenues
  55. [55] Item 1A, Risk Factors — We may not be able to complete our initial business combination within the prescribed time frame
  56. [56] Item 1A, Risk Factors — Because of our limited resources and the significant competition for business combination opportunities
  57. [57] Item 1A, Risk Factors — The ability of our Public Shareholders to redeem their shares for cash may make our financial condition unattractive
  58. [58] Item 1A, Risk Factors — If third parties bring claims against us, the proceeds held in the Trust Account could be reduced
  59. [59] Item 7, MD&A — Liquidity, Capital Resources and Going Concern
  60. [60] Item 1A, Risk Factors — Our ability to complete a business combination may be impacted by the fact that certain of our Sponsors’ limited partners are non-U.S. persons
  61. [61] Item 1A, Risk Factors — We may effect a business combination with a company located outside of the United States
  62. [62] Item 1A, Risk Factors — If we effect our initial business combination with a business located in the PRC
  63. [63] Item 1, Business
  64. [64] Item 1, Business
  65. [65] Item 1, Business
  66. [66] Item 7, MD&A — Liquidity, Capital Resources and Going Concern
  67. [67] Item 9A, Controls and Procedures

Analysis on 5/20/2026